:

Homeland Security

Emergent BioSolutions Acquires VaxGen’s Anthrax Vaccine Technology

DDN

Wednesday, May 14th, 2008

SHARE:

Emergent BioSolutions [EBS] has acquired the assets and rights to a recombinant protective antigen (rPA) anthrax vaccine product candidate and related technology from VaxGen, Inc. [VXGN] for $2 million plus a potential additional $8 million in milestone payments. The arrangement also includes specified percentages of future net sales. VaxGen's original $877 million contract to develop and produce a next-generation anthrax vaccine was terminated by the Department of Health and Human Services in December 2006 due to stability issues with the…

Senators Push Navy Against Single Destroyer Request In FY ’27

The chairman of the Senate Armed Services Committee (SASC) and the two senators from Maine last week pushed back on Navy officials for only requesting one Arleigh Burke-class destroyer (DDG-51) […]

Navy Looks To Eventually Assemble Battleship At HII Newport News; Faces More Dem Opposition

The Navy told lawmakers this week it found a dry dock at HII’s [HII] Newport News Shipbuilding shipyard it thinks can use for final assembly of the new Trump-class battleship […]

Navy Leaders Downplay Looking At Foreign Navy Shipbuilding Amid Lawmaker Objections

The Navy’s top leaders this week seemed to downplay and back down on the service potentially using foreign shipyards to build U.S. Navy ships or buying foreign designed warships overseas […]

Army

Senate Defense Appropriators See ‘Risk’ With Army’s Reconciliation Plan To Fund Munitions Increase

The Senate’s top defense appropriators cited concern this week with the Army’s request to fund the majority of its large increase to munitions procurement in fiscal year 2027 through the […]